Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B

Clinical Nutrition

Volumn 30, Issue 5, 2011, Pages 647-652

  Lee, I Cheng ^a,b   Huang, Yi Hsiang ^a,b   Chan, Che Chang ^a,b   Huo, Teh Ia ^a,b   Chu, Chi Jen ^b   Lai, Chiung Ru ^b   Lee, Pui Ching ^b   Su, Chien Wei ^a,b   Wu, Jaw Ching ^a,b   Lin, Han Chieh ^b   Lee, Shou Dong ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Body mass index; Chronic hepatitis B; Hepatitis B e antigen negative; Hepatitis B virus; Liver histology; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; INFECTION RISK; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RETROSPECTIVE STUDY; TAIWAN; THROMBOCYTE COUNT; VIRUS LOAD;

ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HEPATIC INSUFFICIENCY; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NECROSIS; OBESITY; OVERWEIGHT; PREVALENCE; RETROSPECTIVE STUDIES; TAIWAN; THROMBOCYTOPENIA; VIRAL LOAD;

EID: 80053626300     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.05.001     Document Type: Article

References (30)

1. Ogden C.L., Yanovski S.Z., Carroll M.D., Flegal K.M. The epidemiology of obesity. Gastroenterology 2007, 132:2087-2102.
2. Adams K.F., Schatzkin A., Harris T.B., Kipnis V., Mouw T., Ballard-Barbash R., et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006, 355:763-778.
3. Shoelson S.E., Herrero L., Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007, 132:2169-2180.
4. Ioannou G.N., Weiss N.S., Kowdley K.V., Dominitz J.A. Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study. Gastroenterology 2003, 125:1053-1059.
5. Chen C.L., Yang H.I., Yang W.S., Liu C.J., Chen P.J., You S.L., et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008, 135:111-121.
6. Negro F., Clement S. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C. J Viral Hepat 2009, 16:681-688.
7. Hickman I.J., Clouston A.D., Macdonald G.A., Purdie D.M., Prins J.B., Ash S., et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut 2002, 51:89-94.
8. Everhart J.E., Lok A.S., Kim H.Y., Morgan T.R., Lindsay K.L., Chung R.T., et al. Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. Gastroenterology 2009, 137:549-557.
9. Huang Y.H., Wu J.C., Chang T.T., Sheen I.J., Lee P.C., Huo T.I., et al. Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B patients in Taiwan. J Viral Hepat 2003, 10:277-284.
10. Huang Y.H., Hung H.H., Chan C.C., Lai C.R., Chu C.J., Huo T.I., et al. Core antigen expression is associated with hepatic necroinflammation in e antigen-negative chronic hepatitis B patients with low DNA loads. Clin Vaccine Immunol 2010, 17:1048-1053.
11. Wang Y.Y., Lin S.Y., Sheu W.H., Liu P.H., Tung K.C. Obesity and diabetic hyperglycemia were associated with serum alanine aminotransferase activity in patients with hepatitis B infection. Metabolism 2010, 59:486-491.
12. Wong G.L., Wong V.W., Choi P.C., Chan A.W., Chim A.M., Yiu K.K., et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 2009, 58:111-117.
13. Yu M.W., Shih W.L., Lin C.L., Liu C.J., Jian J.W., Tsai K.S., et al. Body-mass index and progression of hepatitis B: a population-based cohort study in men. J Clin Oncol 2008, 26:5576-5582.
14. Liaw Y.F., Chu C.M. Hepatitis B virus infection. Lancet 2009, 373:582-592.
15. Huang Y.H., Wu J.C., Chang T.T., Sheen I.J., Huo T.I., Lee P.C., et al. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients. J Viral Hepat 2006, 13:336-342.
16. Lee I.C., Huang Y.H., Chan C.C., Huo T.I., Chu C.J., Lai C.R., et al. Correlation between clinical indication for treatment and liver histology in HBeAg-negative chronic hepatitis B: a novel role of alpha-fetoprotein. Liver Int 2010, 30:1161-1168.
17. Lok A.S., McMahon B.J. Chronic hepatitis B: update 2009. Hepatology 2009, 50:661-662.
18. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163.
19. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22:696-699.
20. Lee I.C., Chan C.C., Huang Y.H., Huo T.I., Chu C.J., Lai C.R., et al. Comparative analysis of noninvasive models to predict early liver fibrosis in hepatitis B e antigen-negative chronic hepatitis B. J Clin Gastroenterol 2011, 45(3):278-285.
21. Papatheodoridis G.V., Manesis E.K., Manolakopoulos S., Elefsiniotis I.S., Goulis J., Giannousis J., et al. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?. Hepatology 2008, 48:1451-1459.
22. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999, 94:2467-2474.
23. Lackner C., Struber G., Liegl B., Leibl S., Ofner P., Bankuti C., et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 2005, 41:1376-1382.
24. Iloeje U.H., Yang H.I., Su J., Jen C.L., You S.L., Chen C.J. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006, 130:678-686.
25. Papatheodoridis G.V., Chrysanthos N., Savvas S., Sevastianos V., Kafiri G., Petraki K., et al. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis. J Viral Hepat 2006, 13:303-310.
26. Yun J.W., Cho Y.K., Park J.H., Kim H.J., Park D.I., Sohn C.I., et al. Hepatic steatosis and fibrosis in young men with treatment-naive chronic hepatitis B. Liver Int 2009, 29:878-883.
27. Hui A.Y., Chan H.L., Wong V.W., Liew C.T., Chim A.M., Chan F.K., et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 2005, 100:616-623.
28. Park S.H., Kim D.J., Lee H.Y. Insulin resistance is not associated with histologic severity in nondiabetic, noncirrhotic patients with chronic hepatitis B virus infection. Am J Gastroenterol 2009, 104:1135-1139.
29. Marra F., Bertolani C. Adipokines in liver diseases. Hepatology 2009, 50:957-969.
30. Wong V.W., Wong G.L., Yu J., Choi P.C., Chan A.W., Chan H.Y., et al. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese. Am J Gastroenterol 2010, 105:132-138.